Funding Opportunities
Internal and external funding opportunities collected by the CTSI.
CTSI PilotsThe Translational Pilot Program will solicit, review and award pilot grants designed to produce and test novel tools and methods to bridge translational gaps. |
Ignition FundsProviding ignition funding to accelerate progress for clinical and translational research projects. |
K12 FundingProviding 2-3 years of support for early-career research faculty from Wake Forest. |
Community Partnered Research AwardCommunity Engagement provides funding to support community and academic researchers via the Community Partnered Research Award. |
Special Populations Voucher FundsStudies that identify a financial need can request funds from the voucher program to help overcome barriers related to transportation, child care, etc. |
Team Grant AcceleratorSupporting planning, pre-award, and post-award stages to incentivize investigators to pursue new large awards. |
Internal
Recurring Funding Opportunities:
- CTSI - Translational Pilot Program Ignition Funds - Deadline: 04/01/25
- CTSI - Research Salary Bridge Funding - Deadline: 04/01/25
- CTSI - Early Career Salary Support - Deadline: 04/01/25
School of Medicine and Advocate Health 2024 Requests For Proposals
The WFU Program for Leadership and Character invites proposals from any WFU School of Medicine or AHWFB or Advocate Health System employee with ideas for character development programs for current and/or future clinicians (i.e. students) and/or care team members.
Character in Medicine Grant
The Character in Medicine Grant exists to empower employees of the Wake Forest University and Advocate Health System to design, implement, and/or more rigorously assess educational programs that promote participants’ character development. This grant will fund proposals to launch pilot projects, revise existing programs, and/or implement research and/or assessment on programs to better understand their character growth impacts. Funding amount will vary from $1,000 to $30,000. Projects costing above $7,500 require a preliminary discussion with Elizabeth Whiting and/or Lauren Iley-Spear.
Applications will be accepted on a rolling basis between May 2024 – August 2025. Faculty or staff from The Wake Forest University School of Medicine and Advocate Health System are encouraged to apply. Estimated time required to complete application: 30+ minutes. Download Character in Medicine Grant Application.
Contact Elizabeth Whiting or Lauren Iley-Spear with questions.
April Deadlines
CTSI Science of Translation Rapid Response Pilot RFA
The CTSI has issued a rapid response call for Science of Translation Pilot projects. Due to the rapid turnaround time, we have condensed the application in order to aid in a speedy submission. If you have questions or want to discuss your project idea, please reach out to Brittney Patterson by March 21, 2025.
Please see the RFA for additional information and eligibility details.
Full application deadline: April 9, 2025 at 11:59PM
Cardiovascular Sciences Center 2025 Request for Pilot Awards
The Cardiovascular Sciences Center (CVSC) is seeking proposals for projects in need of support to promote new areas or technologies for cardiovascular research (basic, clinical, population), as well as to foster collaborative efforts or new collaborations. The goal of the pilot project is to allow investigators to pursue novel and innovative ideas that will improve the likelihood of obtaining extramural funding. The funding is also meant to allow investigators to perform critical experiments, access core facilities or improve analyses that address specific critiques raised by reviewers for extramural funding. Additional details can be found in the RFA. For questions about your research project, please contact Dr. Liliya Yamaleyeva.
Successful pilots will receive up to $20,000 to be spent within a 12-month project period. These awards are open to PIs with a rank of instructor or higher from Wake Forest (Health Sciences & University), Atrium Health, or Advocate Health. If funded, the PI is expected to become a member and contribute to the CVSC mission.
Applications should be submitted through the ePilot electronic submission system.
Deadline: April 15, 2025 at 11:59PM ET
Spring Common Deadline Pilot Request for Applications
Pilot funding opportunities are now available through the 2025 Spring Common Deadline! All letters of intent are due April 25th for the participating centers below. For more details, please review the linked RFAs.
|
Center RFA |
Letter of Intent Deadline |
Award Amount |
| Wake Forest Clinical and Tranlsational Science Institute (CTSI) Translational Research | 04/25/2025 at 11:59PM ET | $40,000 |
| Center for Artificial Intelligence Research (CAIR) | 04/25/2025 at 11:59PM ET | $40,000 |
| Center for Health System Sciences (CHASSIS) | 04/25/2025 at 11:59PM ET | $20,000 |
| Center for Prevention Science in Child and Family Health (CPSCHFH) | 04/25/2025 at 11:59PM ET | $40,000 |
|
04/25/2025 at 11:59PM ET |
$40,000 |
Letters of intent should be submitted through the Common Deadline ePilot electronic submission system. Investigators can access the electronic submission link in each RFA.
Research Centers
An Institutionally-Supported Research Center is an interdepartmental unit focused predominantly on translational, clinical and/or basic science research which facilitates development of a common, focused research agenda aligned with strategic priorities, coordinating contributions from multiple disciplines (other centers, divisions/departments, and programs). We are pleased to announce the following opportunities are now available:
- Research Centers – The purpose of this RFA is to invite applications to develop an Institutionally-Supported Advocate Health/Wake Forest University School of Medicine Research Center. This document also provides the framework for a renewal application of an existing center. Research Centers support mature areas of research that reflect depth in translational, clinical and/or basic science research. View the full RFA for Research Centers here.
- Emerging Research Centers - The purpose of this RFA is to invite applications to develop an Institutionally-Supported Advocate Health/Wake Forest University School of Medicine Emerging Research Center. This document also provides the framework for a renewal application of an existing center. Emerging Research Centers support new ideas in need of investment for growth. The investment is intended to catalyze the formation of a team for the specific purpose of developing a strategic vision in order to grow a critical base of extramurally funded research. This research can be established in translational, clinical and/or basic science research. View the full RFA for Emerging Research Centers here.
Direct questions and applications to Lynne Wagenknecht, Vice Dean for Population Health Research, and/or Lindsay Trost, CTSI Administrative Director.
Foundation
Interested applicants may contact the Foundations Relations team at foundations@wakehealth.edu.
| Pediatrics | The Gerber Foundation | Pediatric Research Grant Concept Paper |
$350,000 | 5/15/2025 |
| Gastroenterology | Beyond Celiac | 2025 Beyond Celiac Early Career Research Award |
$200,000 | 5/26/2025 |
| Cancer | Lustgarten Foundation for Pancreatic Cancer Research | Dr. Robert F. Vizza Clinical Accelerator Initiative LOI |
$2,000,000 | 5/30/2025 |
The Duke Endowment
The Duke Endowment has a long history of supporting our health system across the Carolinas.
In accordance with the Endowment's request, all inquiries from the health system will be routed through the designated Philanthropy/Foundation representatives in each market. If you are based in the Charlotte market, please reach out to Rachel Ellis. Those in the Winston market, please contact Chad Daniel.
The Duke Endowment will not accept or review any applications submitted directly by faculty who have not coordinated with the Philanthropy/Foundation representative in their market. This ensures all submissions are properly managed and align with the Endowment's expectations and current funding priorities.
The W.M. Keck Foundation
The W. M. Keck Research Program seeks to benefit humanity by supporting Medical Research projects that are distinctive and novel in their approach, question the prevailing paradigm, or have the potential to break open new territory in their field. The Research Program employs a two-phase application process after an initial concept paper review with the Keck Foundation. All communication with the foundation, including submitting applications, proposals and reports must be via the institution’s designated liaison, the Corporate & Foundation Relations team in the Office of Philanthropy.
For additional information, please see the RFA. Questions regarding the application process should be directed to Joanna Yu. Concept papers should be submitted through the Keck Foundation Funding Submission system.
Deadlines:
Concept Papers Due: April 11, 2025 at 11:59PM
Selection of Awardees: May 5, 2025
Bill & Melinda Gates Foundation Presents Global Grand Challenges
On behalf of the Bill & Melinda Gates Foundation, we are pleased to announce five new Grand Challenges (GC) requests for proposals (RFPs). We encourage you to apply to the Challenges for which you are eligible - and to share this information with other interested parties.
Like all Grand Challenges projects over 20-plus years, the newly announced RFPs will foster innovation to address urgent global priorities, and the grantees, funders, and others in the Grand Challenges network will work in the spirit of partnership to maximize their combined impact.
We invite you to read summaries of selected Grand Challenges grants, explore an interactive world map of projects across the Grand Challenges network, and sign up on the Grand Challenges website to receive email updates.
The deadline for all of the following opportunities is March 25, 2025 at 11:30 AM PDT.
- "Innovations for Gram-Negative Antibiotic Discovery," a unique collaboration among three partners, the Novo Nordisk Foundation, Wellcome, and the Gates Foundation. Through this GC RFP, the partners are launching a new initiative, the Gram-Negative Antibiotic Discovery Innovator (Gr-ADI). Gr-ADI will bring together funders, research institutions, and industry partners to address the problem of anti-microbial resistance, now the third leading cause of death globally. This RFP serves as the source of Gr-ADI's first projects and is focused on the discovery of antibiotics with broad spectrum activity against Enterobacteriaceae, using Klebsiellaspp. as the pathogen to initiate a discovery program.
- "Accelerating Innovations to Address Heavy Menstrual Bleeding in Women in Low-Resource Settings"
- "Enhancing HIV and TB Diagnosis: Adjunct Technologies for Sample Collection and Processing"
- "Innovative Data and Modeling Approaches to Measure Women's Health"
- "Reducing the Burden of Preeclampsia"
The following informational webinars are planned for these opportunities:
Accelerating Innovations to Address Heavy Menstrual Bleeding in Women in Low-Resource Settings:
- February 25, 7:00-8:00 AM Pacific Time - webinar link/submit a question
Enhancing HIV and TB Diagnosis: Adjunct Technologies for Sample Collection and Processing:
- February 26, 6:00-7:00 AM Pacific Time - webinar link/submit a question
Innovations for Gram-Negative Antibiotic Discovery:
- February 27, 6:00-7:00 AM Pacific Time - webinar link/submit a question
Reducing the Burden of Preeclampsia:
- February 27, 7:30-8:30 AM Pacific Time - webinar link/submit a question
NIH
- RFA-AG-24-039: Development and Validation of Harmonized Methodologies to Measure NAD+ and Related Metabolites in Clinical Trials (U01 Clinical Trial Required)
- PAR-23-240: Alcohol and Other Substance Use Research Education Programs for Health Professionals (R25 Clinical Trial Not Allowed)
Professional Associations and Societies
Please refer to the individual Program or Funding Opportunity Announcement for deadline information.
- American Cancer Society
- The Triological Society
- American Heart Association
- American Gastroenterological Association
- American Federation for Aging Research
- Alzheimer's Association
- ALS Association
- American Diabetes Association
- Juvenile Diabetes Research Foundation
- Thoracic Surgery Foundation for Research and Education
- Society for Pediatric Dermatology
Other Opportunities
Robert A. Winn Excellence in Clinical Trials Award Program
The Robert A. Winn Excellence in Clinical Trials Award Program (Winn Awards), a $124.5 million initiative funded by the Bristol Myers Squibb Foundation, Gilead Sciences, Amgen, and Genentech and led by a team at the Virginia Commonwealth University’s Massey Comprehensive Cancer Center is now accepting applications. The Winn Awards is the nation’s premiere program designed to improve participation in clinical trials to drive better health outcomes in all communities to save more lives. The applications are open for one of the signature programs: the Winn Career Development Award (Winn CDA).
Winn CDA is a two year program designed to support the career development of early-stage investigator physicians who have a demonstrated commitment to transforming and expanding access to the clinical research landscape. They will become community-oriented clinical trialists who will drive improved health outcomes through their research and mentoring.
This is an extraordinary opportunity for early-career physician researchers who are committed to improving patient participation in clinical trials and transforming the clinical trials. For more information, please read the award program's flyer here and webpage here.
Application Deadline: Monday, May 12th, 2025
All of Us Research Program
All of Us Research Program Seeks Engagement and Enrollment Partners: The National Institutes of Health's All of Us Research Program has issues a new funding opportunity soliciting proposals to support outreach, community engagement and participant enrollment and retention efforts. The opportunity spans four specific areas of interest, including community, participant and health care provider engagement, enrollment and retention; researcher engagement; Tribal engagement; and integration of participants and advocates in program oversight.
• Proposals will be accepted on an ongoing basis through May 23, 2025
• Read the Full Announcement
NeuroNEXT Grant
The NeuroNEXT Network is designed to efficiently conduct Phase II Clinical Trials. NeuroNEXT Network is now accepting proposals. Applications for exploratory clinical trials of investigational agents (drugs, biologics, surgical therapies or devices) that may contribute to the justification for and provide the data required for designing a future trial, for biomarker validation studies, or for proof of mechanism clinical studies are encouraged. Successful applicants will be given access to the NeuroNEXT infrastructure to support the efficient implementation of the proposed study at multiple sites and statistical and data management.
If you are interested, please schedule a meeting to discuss your proposal with the NeuroNEXT Study Team. This opportunity is ongoing until 2028.
- Benefits of Partnering with NeuroNEXT
- Applying for a NeuroNEXT Grant
- Contact: Mysha Sissine, Program Manager
Additional Resources
Listed below are some quick ways to find external funding opportunities through search mechanisms and announcement listservs.
Additional Resources
- For detailed information on funding opportunities, search www.grants.gov with keywords related to your research interests.
- National Institutes of Health (NIH)
- NIH Career Development Awards (K-Series)
- Patient-Centered Outcomes Research Institute (PCORI)
- Health Resources and Services Administration (HRSA)
- National Science Foundation (NSF)
- North Carolina Biotechnology Center